TP53 and Miyoshi myopathy: MEG3, a gene with tumor suppression functions linked to the p53 pathway, was shown to be differentially hypermethylated in MM patients, with the highest level of methylation seen in patients with a higher tumor burden, evaluated using the Durie and Salmon Staging System.